Nonclinical Testing Services (In Vitro & In Vivo Studies)
Contract Overview
Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.
AI Contract Overview
This contract involves the execution of government-directed nonclinical testing plans for Medical Countermeasure (MCM) candidates, focusing on pharmacokinetics, toxicology, and efficacy studies. The work includes both in vitro and in vivo studies and is intended to support the development and evaluation of these MCM candidates. Animal use for these studies is strictly regulated and allowed only with prior approval from the Animal Care and Use Review Office (ACURO). The contract is categorized as a subcontract under the NAICS code 541611 and is issued by the Department of Defense, specifically through the office identified as W6QK Acc-Apg. The place of performance for the contract is located in Frederick. The solicitation was posted on June 3, 2026, and responses are due by June 22, 2026. There are no specified set-asides for this contract, and the contract emphasizes compliance with ethical standards for animal research and adherence to government-defined testing protocols to ensure the safety and effectiveness of the MCM candidates.
General Info
Agency
NAICS
Place of Performance
Frederick, MD, USASet-Aside
Documents
(0)AI Contract Breakdown
Uniform Contract FormatNo contract breakdown available.
Cannot generate Contract Breakdown because no documents were found from this contract's source.
Timeline
Response Deadline
